Holen Sie sich die Stockscreener-App
0.63
3.15%
-0.0205
Handel nachbörslich:
.64
0.01
+1.59%
Schlusskurs vom Vortag:
$0.6505
Offen:
$0.6498
24-Stunden-Volumen:
200.33K
Relative Volume:
0.53
Marktkapitalisierung:
$43.45M
Einnahmen:
$3.67M
Nettoeinkommen (Verlust:
$-13.83M
KGV:
-2.25
EPS:
-0.28
Netto-Cashflow:
$-10.79M
1W Leistung:
-1.65%
1M Leistung:
-5.21%
6M Leistung:
-41.12%
1J Leistung:
-48.36%
1-Tages-Spanne:
$0.63
$0.6563
1-Wochen-Bereich:
$0.6274
$0.68
52-Wochen-Spanne:
$0.58
$1.66
Icecure Medical Ltd Stock (ICCM) Company Profile
Firmenname
Icecure Medical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ICCM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.63 | 44.86M | 3.67M | -13.83M | -10.79M | -0.28 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Icecure Medical Ltd Aktie (ICCM) Neueste Nachrichten
Aug Sectors: Is IceCure Medical Ltd likely to announce a buybackWeekly Trade Recap & Community Trade Idea Sharing - baoquankhu1.vn
Shorts Report: Is IceCure Medical Ltd forming a breakout patternJobs Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
ICCMIcecure Medical Ltd. Latest Stock News & Market Updates - Stock Titan
When Will IceCure Medical Ltd (NASDAQ:ICCM) Turn A Profit? - Yahoo Finance
Patterns Watch: Is IceCure Medical Ltd showing insider buyingMarket Volume Summary & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Why retail investors pile into IceCure Medical Ltd stockStochastic Oscillator Alerts & High Yield Portfolio Growth - bollywoodhelpline.com
IceCure (ICCM) Achieves Milestone with FDA Authorization for Pro - GuruFocus
IceCure Medical Reports Record 2025 ProSense® Sales Following Landmark FDA Breast Cancer Clearance - TipRanks
IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025 ProSense® Sales - PR Newswire
IceCure Medical’s Earnings Call Highlights Growth Potential - MSN
IceCure Medical Announces Special General Meeting for Key Votes - MSN
IceCure Medical Extends Equity Distribution Agreement with Maxim Group to March 2026 - TipRanks
When Can We Expect A Profit From IceCure Medical Ltd (NASDAQ:ICCM)? - Sahm
Is IceCure Medical Ltd stock dividend yield sustainableJuly 2025 Action & Fast Gain Stock Tips - Улправда
IceCure Medical Shareholders Approve Amended Articles of Association at January 7 Special Meeting - TipRanks
IceCure Medical (ICCM) adopts new Articles after special meeting vote - Stock Titan
Bond Watch: Why IceCure Medical Ltd stock is rated strong buy2025 Trading Recap & Accurate Buy Signal Alerts - moha.gov.vn
How IceCure Medical Ltd stock performs in rate cut cyclesJuly 2025 Analyst Calls & Accurate Entry/Exit Alerts - Улправда
Tech Rally: Why IceCure Medical Ltd stock is rated strong buy2025 Trade Ideas & Daily Risk Controlled Trade Plans - Bộ Nội Vụ
Is IceCure Medical Ltd stock trading at a premium valuationJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - Улправда
What technical signals suggest for IceCure Medical Ltd stockJuly 2025 News Drivers & Real-Time Stock Price Movement Reports - DonanımHaber
Will IceCure Medical Ltd stock benefit from sector rotationInsider Buying & Advanced Technical Analysis Signals - Улправда
Should I hold or sell IceCure Medical Ltd stock in 2025July 2025 Institutional & Stepwise Entry and Exit Trade Signals - Улправда
IceCure Medical : Company Presentation - marketscreener.com
What analysts say about IceCure Medical Ltd stockStock Market Trends & Free Significant Capital Appreciation - earlytimes.in
IceCure Expected to Report Record Fourth Quarter Sales in North - GuruFocus
IceCure (NASDAQ: ICCM) sees record Q4 North America sales after FDA clearance - Stock Titan
IceCure Expected to Report Record Fourth Quarter Sales in North America Driven by Recent FDA Clearance of ProSense® Cryoablation for Low-Risk Breast Cancer - Sahm
IceCure's ProSense® Cryoablation Featured in 4 Independent Breast Cancer Studies Presented at Radiological Society of America 2025 Annual Meeting - PR Newswire
Icecure Medical Ltd. Announces Prosense Cryoablation Featured in 4 Independent Breast Cancer Studies Presented At Radiological Society of America 2025 Annual Meeting - marketscreener.com
Cryoablation: The Minimally Invasive Freezing Technology That's a Game-Changer for Treating Low-Risk, Early-Stage Breast Cancer - Future of Personal Health -
IceCure Medical (Nasdaq: ICCM) data show ProSense cuts AWE pain scores to 1 - Stock Titan
IceCure Receives Notice of Patent Allowance in China for a Novel Cryogen Flow Control to Optimize Patient Cryoablation Outcomes - marketscreener.com
Is IceCure Medical Ltd a good long term investmentStop Loss Placement Tips & Turn Bull Runs into Life-Changing Wealth - earlytimes.in
Icecure Receives Notice of Patent Allowance in China for A Novel Cryogen Flow Control to Optimize Patient Cryoablation Outcomes - marketscreener.com
IceCure Medical (ICCM) Secures Patent Approval in China for Cryo - GuruFocus
IceCure Receives Notice of Patent Allowance in China for a Novel - GuruFocus
IceCure Medical Secures Patent in China for Cryogen Flow Control - TipRanks
Why IceCure Medical Ltd stock remains on buy listsJuly 2025 Movers & Real-Time Volume Analysis Alerts - Newser
How IceCure Medical Ltd stock benefits from global expansionJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - Newser
ICCM SEC FilingsIcecure Medical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
IceCure Medical schedules special shareholder meeting for January 2026 By Investing.com - Investing.com Canada
IceCure Medical schedules special shareholder meeting for January 2026 - Investing.com
Icecure Medical (ICCM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
IceCure's ProSense® Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances (PR Newswire) - Aktiellt
Icecure Medical Ltd (ICCM) Q3 2025 Earnings Call Highlights: Nav - GuruFocus
Icecure Medical Ltd (ICCM) Q3 2025 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance
Finanzdaten der Icecure Medical Ltd-Aktie (ICCM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):